tirzepatide march 19 2025 🚨March 19! If you haven’t heard, is the last day to get your compounded according to the new ruling by FDA. If you have refills, now is the time to get them. Stock up before it’s What are the changes to

New England Journal of Medicine, 2019.

A global community of 32,000 medical doctors, we protect sight and empower lives by setting the standards for ophthalmic education and advocating for our patients and the public

GLP-1 receptor agonists (glucagon-like peptide-1 receptor agonists) are a class of prescription medications originally developed for type 2 diabetes that have shown remarkable effectiveness for weight management

Educational resources from scientific organizations, peer-reviewed publications, and peptide research websites can provide additional information

Licensed providers can modify a patient's dosage at any time based on medical history, progress, and weight loss goals

Before starting GLP-1s, respondents reported an average weight of 241 lbs